ATP6AP1L
V-type proton ATPase subunit S1-like protein
Also known as: VAS1L_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for ATP6AP1L in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
224 residues, UniProt reviewed canonical sequence.
>Q52LC2|ATP6AP1L
1 MRLWKARVLK LVLKTAKDSR LGLNSKWLSL KLGDAGNPRS LAIRFILTNY NKLSIQSWFS
61 LRRVEIISNN SIQAVFNPTG VYAPSGYSYR CQRVGSLQQD QALLLPSDTD DGSSLWEVTF
121 IDFQIQGFAI KGGRFTKAQD CASSFSPAFL IGLAMSLILL LVLAYALHML IYLRYLDQQY
181 DLIASPAHFS QLKARDTAEE KELLRSQGAE CYKLRSQQIS KIYVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP6AP1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.34
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
- cytoplasmic vesicle membrane
- endomembrane system
- bounding membrane of organelle
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP6AP1L as an antibody target. Whether an autoantibody or antibody against ATP6AP1L could matter depends on whether native ATP6AP1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP6AP1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP6AP1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...